![Paulo Pacheco da Fontoura](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Paulo Pacheco da Fontoura first degree
Entity | Entity type | Industry | |
---|---|---|---|
Trophos SA
![]() Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Paulo Pacheco da Fontoura via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
Ernst & Young LLP
![]() Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sanofi-Synthelabo Canada, Inc. | Corporate Officer/Principal | ||
Université des Sciences et Technologies de Lille | College/University | Graduate Degree | |
Roche Palo Alto LLC
![]() Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Sales & Marketing | |
The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree | |
Parke-Davis Pharmaceutical Research, Inc. | Corporate Officer/Principal | ||
Pfizer Holding France SCA
![]() Pfizer Holding France SCA Pharmaceuticals: MajorHealth Technology Pfizer Holding France SCA manufactures and supplies pharmaceutical products. The company was founded in 1961 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Boehringer Ingelheim France SASU
![]() Boehringer Ingelheim France SASU Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim France SAS engages in the research, development, marketing, and distribution of pharmaceuticals. The company was founded on October 31, 1986 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Université de Technologie de Compiègne | College/University | Doctorate Degree | |
GROUPE FLO | Restaurants | Corporate Officer/Principal | |
Tiempo SAS
![]() Tiempo SAS SemiconductorsElectronic Technology Tiempo SAS provides chip solutions and platforms for use in semiconductors. It offers TESIC, microcontrollers, cryptoprocessors, ACC, and design services. The company was founded by Serge Maginot and Marc Renaudin in July 2007 and is headquartered in Montbonnot Sain Martin, France. | Semiconductors | Director/Board Member | |
PharmaPart AG
![]() PharmaPart AG Miscellaneous Commercial ServicesCommercial Services Part of P Farmaceutici SAS di Canio Giovanni Mazzaro & C., PharmaPart AG provides contract research and consultancy services for the pharmaceutical industry. The company is based in Thalwil, Switzerland. PharmaPart was acquired by P Farmaceutici SAS di Canio Giovanni Mazzaro & C. on July 13, 2005. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Faculty of Pharmaceutical Medicine | Corporate Officer/Principal | ||
Drug Information Association
![]() Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BIOXXMED AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Conseil Plus Gestion SAS /Venture Capital/
![]() Conseil Plus Gestion SAS /Venture Capital/ Investment ManagersFinance Conseil Plus Gestion SAS /Venture Capital/ (CPG Capital-Investissement) is the private subsidiary of Conseil Plus Gestion SAS. The firm was founded by Jean-Louis Hostache in 1999. The firm is headquartered in Aix en Provence, France. | Investment Managers | Private Equity Investor | |
Roche Latvija SIA
![]() Roche Latvija SIA Pharmaceuticals: MajorHealth Technology Roche Latvija SIA engages in the sale and distribution of medicine, laboratory products, and diagnostics solutions. The company was founded in 1993 and is headquartered in Riga, Latvia. | Pharmaceuticals: Major | Chief Executive Officer | |
France Biotech Association
![]() France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member | |
Horama SA
![]() Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer | |
AB SCIENCE | Pharmaceuticals: Other | Director/Board Member | |
Euromed Management | College/University | Undergraduate Degree | |
Roche Holding (UK) Ltd.
![]() Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Roche Holding (UK) Ltd. manufactures and sells drugs. It operates as a holding company for Roche Products Ltd. and Roche Diagnostics Ltd. Its pharmaceuticals include Copegus, a hepatitis C therapy, HIV inhibitor Fuzeon, and breast cancer therapy, Herceptin. The firm's consumer and professional tests include Accutrend glucose monitoring systems, CoaguChek blood coagulation tests, and the Amplicor line of DNA disease diagnostics. The company was founded in 1908 and is headquartered in Welwyn Garden City, UK. | Pharmaceuticals: Major | Director/Board Member | |
Roche Innovation Center Copenhagen A/S
![]() Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Roche Products Ltd.
![]() Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Roche Products Ltd. manufactures diagnostic, diabetes, and pharmaceutical products. The company was founded on December 14, 1908 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
École Centrale Paris | College/University | Undergraduate Degree | |
Swiss-Chinese Chamber of Commerce
![]() Swiss-Chinese Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Swiss-Chinese Chamber of Commerce engages in operation of a non-profit organization that provides close ties with Swiss and Chinese authorities, with economic associations, and companies and with the media. The company was founded in 1980 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Roche Kapitalmarkt AG
![]() Roche Kapitalmarkt AG Finance/Rental/LeasingFinance Part of Roche Holding AG, Roche Kapitalmarkt AG is a financing subsidiary/special purpose entity. The company is based in Basel, Switzerland. | Finance/Rental/Leasing | Director/Board Member | |
ACG Management SAS
![]() ACG Management SAS Investment ManagersFinance ACG Management SAS (ACG) is the private equity subsidiary of Vivéris Holding SAS in France. The firm was formerly known as Vivéris Management SAS, established in 2000, and became ACG Management in 2014. Based in Marseille, with additional offices in Ajaccio and St. Denis de la Réunion and subsidiaries in New Caledonia and Tunisia, ACG is a multi-regional firm which provides technology venture capital, development capital, capital transmission and LBO services as well as a range of investment vehicles, including FCPIs, FIPs and FCPRs for institutional investors. | Investment Managers | Founder | |
PALUMED SA
![]() PALUMED SA Pharmaceuticals: MajorHealth Technology PALUMED SA develops and produces pharmaceutical products for the treatment of Alzheimer's disease. The firm specializes in the development and production of new antimalarial agents and antibacterial molecules. The company was founded on December 8, 2000 and is headquartered in Castanet-Tolosan, France. | Pharmaceuticals: Major | Director/Board Member | |
TRAQUEUR | Electronics/Appliances | Director/Board Member | |
Emix SAS
![]() Emix SAS Other Metals/MineralsNon-Energy Minerals Emix SAS manufactures and markets blocks, plates, and wafers of polycrystalline silicon that are used in solar photovoltaic applications. It specializes in the purification and crystallization of multicrystalline silicon. The firm’s products include wide and flat multi-crystalline silicon blocks. The company was founded by Didier Landaud and Patrick Paillere in 1999 and is headquartered in Saint-Maurice-la-Souterraine, France. | Other Metals/Minerals | Director/Board Member | |
Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Doctorate Degree |
Statistics
International
France | 20 |
United States | 5 |
Germany | 5 |
Switzerland | 4 |
United Kingdom | 4 |
Sectoral
Health Technology | 14 |
Consumer Services | 8 |
Commercial Services | 6 |
Finance | 4 |
Electronic Technology | 3 |
Operational
Director/Board Member | 17 |
Corporate Officer/Principal | 16 |
Chief Executive Officer | 6 |
Chairman | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Most connected contacts
- Stock Market
- Insiders
- Paulo Pacheco da Fontoura
- Company connections